Invention Grant
- Patent Title: Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
-
Application No.: US15158638Application Date: 2016-05-19
-
Publication No.: US10023650B2Publication Date: 2018-07-17
- Inventor: J. Andrew Bristol , Judith A. Kantor
- Applicant: PRECISION BIOLOGICS, INC.
- Applicant Address: US MD Rockville
- Assignee: PRECISION BIOLOGICS, INC.
- Current Assignee: PRECISION BIOLOGICS, INC.
- Current Assignee Address: US MD Rockville
- Agency: LeClairRyan PLLC
- Agent Robin L. Teskin
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/30 ; A61K39/395 ; A61K45/06 ; C07K16/18 ; G01N33/574 ; A61K47/48 ; G01N33/577 ; A61K39/00
Abstract:
The present invention provides for recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens, along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to the nucleic acids, and uses for these antibodies, nucleic acids and amino acids.
Public/Granted literature
- US20160326260A1 RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS Public/Granted day:2016-11-10
Information query
